Literature DB >> 28286267

Over-expression of CHAF1A in Epithelial Ovarian Cancer can promote cell proliferation and inhibit cell apoptosis.

Dandan Xia1, Xiaoming Yang1, Wenxue Liu1, Fangqian Shen1, Jufang Pan1, Yu Lin1, Na Du1, Yunyan Sun1, Xiaowei Xi2.   

Abstract

Chromatin Assembly Factor 1, subunit A (CHAF1A) can regulate cell proliferation, DNA repair and epigenetic changes in embryonic stem cells and it has been reported that over-expression of CHAF1A is associated with several human diseases including cancer. However, the expression and function of CHAF1A in Epithelial Ovarian Cancer (EOC) are rarely reported at present. In this study, we found that the positive staining of CHAF1A in EOC was higher than that in normal tissues and over-expression of CHAF1A was strongly associated with cancer stage and lymph node metastasis. Knockdown of CHAF1A by siRNA in EOC inhibited cell proliferation, reduced colony formation, caused G0/G1 phase arrest and promoted cell apoptosis. Taken together, the high expression of CHAF1A promotes cell proliferation and inhibits cell apoptosis and CHAF1A may be developed as a prognosis biomarker and potential therapeutic target of EOC.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; CHAF1A; Cell cycle; Epithelial Ovarian Cancer; Proliferation

Mesh:

Substances:

Year:  2017        PMID: 28286267     DOI: 10.1016/j.bbrc.2017.03.026

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  FMR1/circCHAF1A/miR-211-5p/HOXC8 feedback loop regulates proliferation and tumorigenesis via MDM2-dependent p53 signaling in GSCs.

Authors:  Yang Jiang; Zhenlin Wang; Chenting Ying; Jiangfeng Hu; Tao Zeng; Liang Gao
Journal:  Oncogene       Date:  2021-05-20       Impact factor: 9.867

2.  CHAF1A, the largest subunit of the chromatin assembly factor 1 complex, regulates the growth of H1299 human non-small cell lung cancer cells by inducing G0/G1 cell cycle arrest.

Authors:  Tanzhen Liu; Jingjing Wei; Chao Jiang; Chen Wang; Xiaoqin Zhang; Yan Du; Jianqiang Li; Hui Zhao
Journal:  Exp Ther Med       Date:  2017-09-25       Impact factor: 2.447

3.  Knockdown of ALPK2 inhibits the development and progression of Ovarian Cancer.

Authors:  Xiaogang Zhu; Siqi Yan; Songshu Xiao; Min Xue
Journal:  Cancer Cell Int       Date:  2020-06-24       Impact factor: 5.722

Review 4.  Unresolved Complexity in the Gene Regulatory Network Underlying EMT.

Authors:  Deborah P Lavin; Vijay K Tiwari
Journal:  Front Oncol       Date:  2020-05-12       Impact factor: 6.244

5.  Antibacterial Therapy by Ag+ Ions Complexed with Titan Yellow/Congo Red and Albumin during Anticancer Therapy of Urinary Bladder Cancer.

Authors:  Anna Jagusiak; Tomasz Gosiewski; Dorota Romaniszyn; Małgorzata Lasota; Anna Wiśniewska; Katarzyna Chłopaś; Barbara Ostrowska; Izabela Kościk; Małgorzata Bulanda
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

6.  High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer.

Authors:  Zhehan Bao; Yanqiang Zhang; Pengcheng Yu; Yi Wang; Can Hu; Yuhang Xia; Li Yuan; Zhiyuan Xu; Xiangdong Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-19       Impact factor: 2.650

7.  Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells.

Authors:  Gulcin Tezcan; Mohammad Alsaadi; Shaimaa Hamza; Ekaterina E Garanina; Ekaterina V Martynova; Gulshat R Ziganshina; Elina R Farukshina; Albert A Rizvanov; Svetlana F Khaiboullina
Journal:  Int J Mol Sci       Date:  2022-08-22       Impact factor: 6.208

Review 8.  Challenging, Accurate and Feasible: CAF-1 as a Tumour Proliferation Marker of Diagnostic and Prognostic Value.

Authors:  Alexandros G Sykaras; Alexandros Pergaris; Stamatios Theocharis
Journal:  Cancers (Basel)       Date:  2021-05-24       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.